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Wharton’s jelly mesenchymal stromal cells (WJ-MSCs) have a unique ability to 
cross lineage borders. Their immunomodulatory and anti-inflammatory features, fur-
ther render these cells promising for regenerative medicine applications. Few data are 
present in literature on the expression of immunomodulatory molecules in umbilical 
cord (UC) tissue and their maintenance in paired cultured WJ-MSCs, an important 
aspect in cellular therapy applications. In addition, few data exist on the maintenance 
of expression of immunomodulatory molecules in mature cell types differentiated 
from MSCs. Therefore we investigated, in vivo (in UC at full term) and in vitro (in 
either undifferentiated or differentiated WJ-MSCs), the expression of different markers 
and their maintenance alongside cell culture, ex vivo expansion and differentiation.
IHC, ICC, RT-PCR and flow cytometry were used to detect expression of markers 
in both paired UC sections and WJ-MSCs. Differentiation was performed towards the 
standard mesenchymal lineages as well as hepatocyte-like cells.
Paired ICC and IHC analyses showed that for most of the analyzed molecules the 
expression at the protein level is maintained in both UC tissue and WJ-MSCs. Struc-
tural molecules were expressed in both WJ and umbilical epithelium (UE), as well 
as in WJ-MSCs. We showed for the first time that UE and WJ were positive for both 
HLA-ABC and HLA-E, while HLA-DR was not detectable. The same data were con-
firmed on WJ-MSCs. Both B7-1 and B7-2 were absent in UC and WJ-MSCs, while 
we showed for the first time that B7-H3 was highly expressed in both WJ and WJ-
MSCs. Differentiation experiments showed that immunomodulatory molecules were 
expressed upon application of complex differentiation protocols, in parallel to the 
acquisition of mature markers or functions.
Some important conclusions may be drawn from the current experiments: i) WJ-
MSCs mostly maintain the expression of molecules just present in their “niche”, under 
standard culture conditions; ii) the parallel expression of immunomodulatory molecules 
sheds new light on the ability of WJ-MSCs to modulate host immune responses; iii) the 
in vivo expression of molecules such as HLA-E and B7-H3 opens new questions on the 
role of WJ during pregnancy; iv) the expression of these molecules in differentiated cells 
provides key features for in vivo applications, in particular for hepatocyte-like cells.
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